UB
REGN icon

UMB Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

UMB Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$821K Buy
1,062
+2
+0.2% +$1.53K 0.01% 387
2025
Q4 		$818K Buy
1,060
+11
+1% +$7.47K 0.01% 392
2025
Q3 		$590K Buy
1,049
+84
+9% +$47.5K 0.01% 406
2025
Q2 		$507K Sell
965
-76
-7% -$42.4K 0.01% 414
2025
Q1 		$660K Buy
1,041
+157
+18% +$108K 0.01% 376
2024
Q4 		$630K Sell
884
-24
-3% -$20.1K 0.01% 382
2024
Q3 		$955K Buy
908
+10
+1% +$11.1K 0.01% 331
2024
Q2 		$944K Buy
898
+92
+11% +$89.2K 0.02% 330
2024
Q1 		$776K Hold
806
– – 0.01% 354
2023
Q4 		$708K Sell
806
-17
-2% -$14K 0.01% 373
2023
Q3 		$677K Sell
823
-150
-15% -$118K 0.01% 374
2023
Q2 		$699K Buy
973
+3
+0.3% +$2.31K 0.01% 381
2023
Q1 		$797K Sell
970
-226
-19% -$170K 0.01% 359
2022
Q4 		$863K Hold
1,196
– – 0.01% 358
2022
Q3 		$824K Sell
1,196
-1
-0.1% -$629 0.01% 368
2022
Q2 		$707K Sell
1,197
-43
-3% -$28K 0.01% 414
2022
Q1 		$866K Buy
1,240
+43
+4% +$27.2K 0.01% 410
2021
Q4 		$756K Buy
1,197
+625
+109% +$384K 0.01% 424
2021
Q3 		$346K Sell
572
-6
-1% -$3.73K 0.01% 317
2021
Q2 		$323K Sell
578
-12,621
-96% -$6.39M 0.01% 316
2021
Q1 		$6.25M Buy
13,199
+4,455
+51% +$2.17M 0.15% 122
2020
Q4 		$4.22M Buy
8,744
+7,691
+730% +$4.15M 0.11% 130
2020
Q3 		$657K Hold
1,053
– – 0.02% 234
2020
Q2 		$657K Buy
+1,053
New +$598K 0.02% 234
2017
Q4 		– Sell
-4,022
Closed -$1.8M – 336
2017
Q3 		$1.8M Sell
4,022
-80
-2% -$38.1K 0.06% 173
2017
Q2 		$2.02M Buy
+4,102
New +$1.8M 0.07% 164

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

UMB Bank's REGN Position: Q1 2026 in Review

UMB Bank increased its Regeneron Pharmaceuticals (REGN) stake by 0.19% in Q1 2026, buying an estimated $1.53K and bringing the position to 1,062 shares worth $821K. The position accounts for 0.01% of the portfolio, ranked #387.

UMB Bank first reported a position in REGN in Q2 2017 and has held it in 26 quarters since. The position peaked at $6.25M in Q1 2021. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • UMB Bank held 1,062 shares of Regeneron Pharmaceuticals worth $821K as of Q1 2026.
  • UMB Bank bought 2 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $1.53K.
  • Regeneron Pharmaceuticals made up 0.01% of UMB Bank's portfolio in Q1 2026, its #387 holding.
  • UMB Bank first reported a position in Regeneron Pharmaceuticals in Q2 2017 and has held it in 26 quarters since.
  • UMB Bank's Regeneron Pharmaceuticals position peaked at $6.25M in Q1 2021.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.